Author Information
Anne-Claude Gingras is affiliated with the Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, in Toronto, Ontario, Canada. Additionally, she holds a position in the Department of Molecular Genetics at the University of Toronto, also located in Toronto, Ontario, Canada. Her research is primarily focused on genetics and molecular biology, contributing significantly to these fields.Research Contributions
Throughout 2022, Anne-Claude Gingras has made substantial contributions to the understanding of SARS-CoV-2 and its variants, COVID-19 vaccination responses, and genome sequencing. Her work includes studies on the immunogenicity of vaccines against different SARS-CoV-2 variants, the waning immunity in patients with immune-mediated inflammatory diseases, and the safety and efficacy of preventative COVID-19 vaccines. Additionally, she has explored genome sequencing results in ostensibly healthy COVID-19 positive individuals and identified novel regulators of p53 stability through genome-wide CRISPR screens. Her research also extends to the field of transcriptional activators in human cells and the interaction of mammalian V-ATPase with proteins through CryoEM analysis.Aliases
Anne-Claude Gingras has published under various names, including: Anne Claude Gingras
A-c Gingras
A. C. Gingras
A.c. Gingras
Anne-Claude Gingras
A C Gingras
Anne-claude Gingras
A.-c. Gingras
Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
46,589 |
| H-index |
104 |
| Paper Count |
498 |
